Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.

被引：0
|
作者：
Russo, Ricardo A. [1 ]
Katsicas, Maria M. [1 ]
机构：
[1] Hosp Pediat, Buenos Aires, DF, Argentina
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S681 / S682
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115
  • [32] DRAMATIC RESPONSE OF CACHEXIA TO ANTI-TNF THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS
    Harrison, K.
    McDonagh, J. E.
    RHEUMATOLOGY, 2014, 53 : 16 - 16
  • [33] Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
    Semeraro, Francesco
    Arcidiacono, Barbara
    Nascimbeni, Giuseppe
    Angi, Martina
    Parolini, Barbara
    Costagliola, Ciro
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 341 - 348
  • [34] The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    Allez, M.
    Vermeire, S.
    Mozziconacci, N.
    Michetti, P.
    Laharie, D.
    Louis, E.
    Bigard, M. -A.
    Hebuterne, X.
    Treton, X.
    Kohn, A.
    Marteau, P.
    Cortot, A.
    Nichita, C.
    van Assche, G.
    Rutgeerts, P.
    Lemann, M.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 92 - 101
  • [35] Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis
    Tynjala, P.
    Lahdenne, P.
    Vahasalo, P.
    Kautiainen, H.
    Honkanen, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) : 1044 - 1049
  • [36] ABATACEPT AND ANTI-TNF MONOCLONAL ANTIBODIES: EFFICACY AND SAFETY COMPARISONS
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 461 - 462
  • [37] Abatacept and anti-TNF monoclonal antibodies: efficacy and safety comparisons
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 103 - 103
  • [38] Efficacy of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.
    van de Putte, BA
    Rau, R
    Breedveld, FC
    Kalden, JR
    Malaise, MG
    Schattenkirchner, M
    Emery, P
    Burmester, GR
    Zeidler, H
    Moutsopoulos, HH
    Compagnone, D
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S400 - S400
  • [39] Efficacy of etanercept in the treatment of juvenile idiopathic arthritis
    de Inocencio Arocena, J.
    Merino Munoz, R.
    Alvarez Madrid, C.
    Garcia-Consuegra Molina, J.
    ANALES DE PEDIATRIA, 2009, 70 (04): : 354 - 361
  • [40] Safety and Efficacy of Etanercept in a Cohort of Patients with Juvenile Idiopathic Arthritis Under 4 Years of Age
    Bracaglia, Claudia
    Buonuomo, Paola S.
    Tozzi, Alberto E.
    Pardeo, Manuela
    Nicolai, Rebecca
    Campana, Andrea
    Insalaco, Antonella
    Cortis, Elisabetta
    De Benedetti, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (06) : 1287 - 1290
12345